In summary, our studies suggest that the synergistic expression and action of TRIB3, EGFR, and PKCα establish a TRIB3–PKCα–WWP1 regulatory axis to promote NSCLC development by enhancing EGFR recycling, stability, and signaling. Here, TRIB3 is linked to non-small cell lung carcinoma.